Published in Biochim Biophys Acta on June 12, 1993
Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol Ther (2011) 1.23
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. Br J Cancer (1995) 1.16
Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model. Clin Cancer Res (2005) 1.01
Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim Biophys Acta (1986) 7.07
Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim Biophys Acta (1979) 5.39
Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta (1985) 4.47
Osmotic properties of large unilamellar vesicles prepared by extrusion. Biophys J (1993) 3.11
X-ray diffraction study of the polymorphic behavior of N-methylated dioleoylphosphatidylethanolamine. Biochemistry (1988) 2.75
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther (2001) 2.35
Smoothed orientational order profile of lipid bilayers by 2H-nuclear magnetic resonance. Biophys J (1989) 2.33
Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc Natl Acad Sci U S A (1988) 2.22
Lipid polymorphism: the molecular basis of nonbilayer phases. Annu Rev Biophys Biophys Chem (1985) 2.14
Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta (1985) 2.05
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim Biophys Acta (2001) 1.78
Effects of fusogenic agent on membrane structure of erythrocyte ghosts and the mechanism of membrane fusion. Nature (1978) 1.74
The polymorphic phase behaviour of phosphatidylethanolamines of natural and synthetic origin. A 31P NMR study. Biochim Biophys Acta (1978) 1.73
Acyl chain orientational order in the hexagonal HII phase of phospholipid-water dispersions. Biophys J (1988) 1.68
Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. Biophys J (2001) 1.64
Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat (2008) 1.64
Influence of transbilayer area asymmetry on the morphology of large unilamellar vesicles. Biophys J (1995) 1.64
Lipid polymorphism and the roles of lipids in membranes. Chem Phys Lipids (1986) 1.64
Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J Biol Chem (1992) 1.63
Modulation of the orientational order profile of the lipid acyl chain in the L alpha phase. Eur Biophys J (1990) 1.60
Liposome encapsulated vincristine: preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogs. Anticancer Drugs (1994) 1.59
Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci Rep (2002) 1.53
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta (1986) 1.52
Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents. Biochim Biophys Acta (1985) 1.49
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res (1989) 1.47
Cytochrome c specifically induces non-bilayer structures in cardiolipin-containing model membranes. Biochim Biophys Acta (1980) 1.47
Phospholipid asymmetry in large unilamellar vesicles induced by transmembrane pH gradients. Biochemistry (1989) 1.39
The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J Immunol (1991) 1.34
Stabilized plasmid-lipid particles: construction and characterization. Gene Ther (1999) 1.33
A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles. Drug Saf (2001) 1.33
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem Phys Lipids (1990) 1.31
Frequency dependence of 31P NMR linewidths in sonicated phospholipid vesicles: effects of chemical shift anisotropy. FEBS Lett (1974) 1.27
Modulation of membrane fusion by asymmetric transbilayer distributions of amino lipids. Biochemistry (1994) 1.26
Developments in liposomal drug delivery systems. Expert Opin Biol Ther (2001) 1.25
Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys J (1997) 1.25
Influence of cholesterol on the structural preferences of dioleoylphosphatidylethanolamine-dioleoylphosphatidylcholine systems: a phosphorus-31 and deuterium nuclear magnetic resonance study. Biochemistry (1982) 1.25
Use of liposomes as injectable-drug delivery systems. Am J Hosp Pharm (1989) 1.24
Comparison of the orientational order of lipid chains in the L alpha and HII phases. Biochemistry (1990) 1.23
Factors affecting the motion of the polar headgroup in phospholipid bilayers. A 31P NMR study of unsonicated phosphatidylcholine liposomes. Biochim Biophys Acta (1976) 1.22
Polymorphic phase behaviour of lipid mixtures as detected by 31P NMR. Evidence that cholesterol may destabilize bilayer structure in membrane systems containing phosphatidylethanolamine. Biochim Biophys Acta (1978) 1.22
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim Biophys Acta (1990) 1.21
Poly(ethylene glycol)--lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry (1996) 1.20
Roles of lipid polymorphism in intracellular delivery. Adv Drug Deliv Rev (2001) 1.19
Application of 31P NMR to model and biological membrane systems. FEBS Lett (1975) 1.19
Techniques for encapsulating bioactive agents into liposomes. Chem Phys Lipids (1986) 1.18
Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim Biophys Acta (1985) 1.18
Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J Pharm Sci (2000) 1.18
On the mechanism of transbilayer transport of phosphatidylglycerol in response to transmembrane pH gradients. Biochemistry (1990) 1.18
Transbilayer transport of phosphatidic acid in response to transmembrane pH gradients. Biochemistry (1991) 1.17
Lateral diffusion rates of phosphatidylcholine in vesicle membranes: effects of cholesterol and hydrocarbon phase transitions. FEBS Lett (1976) 1.16
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. Br J Cancer (1995) 1.16
Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem (1986) 1.14
Fusion of phospholipid vesicles in association with the appearance of lipidic particles as visualized by freeze fracturing. Biochim Biophys Acta (1979) 1.14
Liposomal doxorubicin. J Drug Target (1996) 1.13
Effects of tumbling and lateral diffusion on phosphatidylcholine model membrane 31P-NMR lineshapes. Biochim Biophys Acta (1980) 1.12
Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study. Biochim Biophys Acta (1998) 1.11
Polymorphism of phosphatidylglycerol-phosphatidylethanolamine model membrane systems: a 31p NMR study. Biochem Biophys Res Commun (1980) 1.11
31P NMR studies of unsonicated aqueous dispersions of neutral and acidic phospholipids. Effects of phase transitions, p2H and divalent cations on the motion in the phosphate region of the polar headgroup. Biochim Biophys Acta (1976) 1.11
Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids. Biophys J (2000) 1.11
Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochim Biophys Acta (1998) 1.11
Poly(ethylene glycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids. Biochemistry (1996) 1.11
Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity. Nat Biotechnol (1999) 1.10
Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry (1996) 1.10
Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim Biophys Acta (1994) 1.10
Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J Biol Chem (1995) 1.09
Lipid polymorphism and hydrocarbon order. Biochem Cell Biol (1990) 1.09
Influence of local and neutral anaesthetics on the polymorphic phase preferences of egg yolk phosphatidylethanolamine. Biochim Biophys Acta (1981) 1.08
Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia. Cancer Chemother Pharmacol (1993) 1.07
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. Cancer Res (1994) 1.07
The lipidic particle as an intermediate structure in membrane fusion processes and bilayer to hexagonal HII transitions. Biochim Biophys Acta (1980) 1.07
Application of 31P-NMR saturation transfer techniques to investigate phospholipid motion and organization in model and biological membranes. Biochim Biophys Acta (1980) 1.06
Correlation between lipid plane curvature and lipid chain order. Biophys J (1996) 1.05
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours. Br J Cancer (1995) 1.05
Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma. Anal Biochem (1990) 1.05
Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim Biophys Acta (1997) 1.04
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors. Cancer Res (1990) 1.04
Differential scanning calorimetry and 31P NMR studies on sonicated and unsonicated phosphatidylcholine liposomes. Biochim Biophys Acta (1975) 1.04
Effects of cholesterol on the properties of equimolar mixtures of synthetic phosphatidylethanolamine and phosphatidylcholine. A 31P NMR and differential scanning calorimetry study. Biochim Biophys Acta (1978) 1.04
Effects of divalent cations and pH on phosphatidylserine model membranes: a 31P NMR study. Biochem Biophys Res Commun (1980) 1.04
Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior. Biochim Biophys Acta (2000) 1.03
Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim Biophys Acta (1994) 1.03
Lipid asymmetry induced by transmembrane pH gradients in large unilamellar vesicles. J Biol Chem (1987) 1.02
Optimized procedures for the coupling of proteins to liposomes. J Immunol Methods (1990) 1.02
Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). J Pharmacol Exp Ther (1997) 1.01